General anesthesia with remimazolam in a patient with clinically suspected malignant hyperthermia

Affiliations

¹ Department of Anesthesiology, The Jikei University School of Medicine, 3-25-8 Nishishimbashi, Minatoku, Tokyo, 105-8461, Japan.
² Department of Anesthesiology, The Jikei University School of Medicine, 3-25-8 Nishishimbashi, Minatoku, Tokyo, 105-8461, Japan. hs-031@jikei.ac.jp.

Keita Uchiyama et al. JA Clin Rep. 2021.

. 2021 Oct 18;7(1):78.

doi: 10.1186/s40981-021-00482-4.

¹ Department of Anesthesiology, The Jikei University School of Medicine, 3-25-8 Nishishimbashi, Minatoku, Tokyo, 105-8461, Japan.
² Department of Anesthesiology, The Jikei University School of Medicine, 3-25-8 Nishishimbashi, Minatoku, Tokyo, 105-8461, Japan. hs-031@jikei.ac.jp.

No abstract available

Conflict of interest statement

The authors declare that they have no competing interests.

1. Gupta PK, Bilmen JG, Hopkins PM. Anaesthetic management of a known or suspected malignant hyperthermia susceptible patient. BJA Educ. 2021;21:218–224. doi: 10.1016/j.bjae.2021.01.003. - DOI - PMC - PubMed
1. Watanabe T, Miyoshi H, Noda Y, Narasaki S, Morio A, Toyota Y, Kimura H, Mukaida K, Yasuda T, Tsutsumi YM. Effects of Remimazolam and Propofol on Ca(2+) Regulation by Ryanodine Receptor 1 with Malignant Hyperthermia Mutation. Biomed Res Int. 2021;2021:8845129. doi: 10.1155/2021/8845129. - DOI - PMC - PubMed
1. GE Healthcare. Technical Report, https://www.gehealthcare.com/-/jssmedia/global/products/files/anesthesia.... Accessed 6 Sept 2021.
1. Mathews EL, Dhamee MS. Propofol in patients susceptible to malignant hyperthermia: a case report and review of the literature. J Clin Anesth. 1992;4:331–332. doi: 10.1016/0952-8180(92)90141-m. - DOI - PubMed
1. Dewachter P, Kopac P, Laguna JJ, Mertes PM, Sabato V, Volcheck GW, Cooke PJ. Anaesthetic management of patients with pre-existing allergic conditions: a narrative review. Br J Anaesth. 2019;123:e65–e81. doi: 10.1016/j.bja.2019.01.020. - DOI - PubMed